US Patent Issued to Fraunhofer-Gesellschaft Zur Forderung Der Angewanditen Forschung on Jan. 27 for "Biological and synthetic molecules inhibiting respiratory syncytial virus infection" (German Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,514, issued on Jan. 27, was assigned to Fraunhofer-Gesellschaft Zur Forderung Der Angewanditen Forschung (Munich).

"Biological and synthetic molecules inhibiting respiratory syncytial virus infection" was invented by David Michael Smith (Leipzig, Germany), Christin Moser (Muldestausee, Germany), Thomas Grunwald (Leipzig, Germany), Leila Issmail (Leipzig, Germany), Christian Jager (Halle, Germany), Martin Kleinschmidt (Halle, Germany), Daniel Ramsbeck (Halle, Germany) and Mirko Buchholz (Halle, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a peptide with a length of 25 amino acids or less comprising the seque...